Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jun 24, 2021 8:50pm
49 Views
Post# 33448766

RE:RE:RE:stockbuphoon, a priority voucher doesnt take months to sell

RE:RE:RE:stockbuphoon, a priority voucher doesnt take months to sellTommyjones, you have absolutely no more than a press release because you are the same flake behind the other 2 boardnames and this lame response proves it. Nothing to add like an analyst would add on market potential as a guy in the business? What will lmnl pursue? It took them years to choose an indication named IPF and they quickly deep sixed that one before the FDA approval. They have not chosen any indications with their preclinical molecules which means they have yet to select indication to target and then set the trial design and then set the recruitment for trials and then doing trial and evaluation. They have 12 months of cash if they can monetize the PRV. Liminal mgmt is saying nothing about anything 4050. Why would that be? Does SALP get all the 4050 IP on bankruptcy? Yep. 

tommyjones1 wrote:

well detailed in at least 2 NRs. Read it.

 

stockbuphoon wrote:

 

The voucher is it business in itself? Wow did you just say that? What's the business producing again? What is liminal producing with the last half $1 billion? Why is management not providing any guidance? Why was liminal announce IPF failure now? 

 

tommyjones1 wrote:

 

that voucher is a business in itself, the only issue is agreeing on a price, takes weeks, not months. It will be done soon imo. They couldnt put it out as collateral if not FDA issued, that just happened, and it's not necessary as it will be delt away shortly. Hope that helps.

i think the jobs posted on lmnl website is a good sign.
 


 




<< Previous
Bullboard Posts
Next >>